Background: The success rate for bilateral exploration in patients with pri
mary hyperparathyroidism approaches 95%. Multiglandular parathyroid hyperpl
asia accounts for approximately 10% to 30% of primary hyperparathyroidism.
The incidence of recurrent or persistent hyperparathyroidism is highest in
familial forms of the disease, in which multiglandular disease is more comm
on; this may be due to asymmetric enlargement of parathyroid glands. Becaus
e of improvements in tumor-imaging capability, some surgeons are now advoca
ting unilateral exploration for primary hyperparathyroidism, but there: is
limited experience concerning how often these imaging methods fail.
Study Design: The outcomes of 7 patients who had sporadic primary hyperpara
thyroidism with multigland hyperplasia were reviewed. We gathered demograph
ic data and laboratory values and reviewed radiologic tests, surgical findi
ngs, pathologic findings, and postoperative followup.
Results: All patients underwent preoperative localization with ultrasonogra
phy and technetium/sestamibi scans. The sensitivity of these two tests for
the dominantly enlarged gland was 100% for both, but dropped to 0% and 5%,
respectively, for all other enlarged glands. The sensitivity of CT and MRI
for the dominant tumor was 67% (2 of 3) and 50% (1 of 2), respectively. Six
of 7 patients underwent subtotal (3 1/2 gland) parathyroidectomy. The mean
volume of all glands was 1.51 +/- 5.89 cm(3) compared with a mean of 5.66
+/- 11.4 cm(3) for all dominant glands and 0.123 +/- 0.1 cm(3) for all nond
ominant hyperplastic glands. There was a large amount of variability betwee
n the volumes of dominant and other glands as demonstrated by large SDs fro
m the mean.
Conclusions: There is a marked heterogeneity in gland size in patients with
sporadic multigland hyperplasia, which is similar to that found in multipl
e endocrine neoplasia type I. This heterogeneity may result in failure to r
ecognize multigland disease if a unilateral neck exploration is performed.
Intraoperative parathyroid hormone assay may prove to be an important adjun
ct in this population of patients who have unsuspected multigland disease.
(J Am Coil Surg 1999;188:382-389, (C) 1999 by the American College of Surge
ons).